Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2026-01-01 @ 7:38 AM
Study NCT ID:
NCT04930432
Status:
RECRUITING
Last Update Posted:
2024-12-27
First Post:
2021-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Sponsor:
Betta Pharmaceuticals Co., Ltd.
Organization: